INTRODUCTION
Problems surrounding our ability to accurately measure dietary intake have been well documented in recent years in the literature (1) (2) (3) . To overcome the measurement error associated with self-reported dietary intake the concept of dietary biomarkers has emerged.
These biomarkers can deliver objective measures of intake and examples include urinary sodium and nitrogen for salt and protein intake respectively (1) . Furthermore, there is evidence that use of biomarkers to develop calibrated equations to correct self-reported intake for estimates for protein and energy intake can positively impact on the ability to examine diet-disease associations: for example inclusion of biomarker calibrated data in the Women's Health Initiative cohorts allowed for disease associations to be revealed that otherwise would not have been identified (4, 5) . Using urinary nitrogen and doubly labelled water as biomarkers to calibrate intakes of protein and energy in a group of postmenopausal women revealed associations between protein and energy intake with diabetes risk. It is noteworthy that these associations were not identified in the uncalibrated data.
The majority of the work to date in this field has focused on energy and protein intake using urinary nitrogen and doubly labelled water as recovery biomarkers. However, recent data has demonstrated that a series of biomarkers including carotenoids, tocopherols, folate, vitamin B12, and phospholipid fatty acids performed as well as established energy (doubly labelled water) and protein (urinary nitrogen) biomarkers in representing nutrient intake (6) . This highlights the potential of widening the nutrients that could be corrected for measurement error using biomarkers and demonstrates that estimating intakes is not limited to recovery biomarkers. Furthermore, data emerging from the application of metabolomics to biomarker discovery has revealed that food intake biomarkers may be used to estimate food intake opening up the possibility of development of calibration equations for intake of foods (7) (8) (9) .
The objective of the present work was to develop calibration equations for citrus intake using urinary proline betaine as the biomarker. Furthermore, we demonstrate through a simulation study the required portion of biomarker measures necessary to enable development of calibration equations in a large population group thus laying the foundations for future work.
Finally, a web application ("Bio-Intake") was developed to perform correction of measurement error in self-reported mean daily citrus intake data, based on the findings of this paper (https://adiet.shinyapps.io/Bio-Intake.)
METHODS

STATISTICAL ANALYSIS
Development of calibration equations for estimation of citrus intake
All data used for the calibration equations was obtained from previously reported studies (7) .
The selection process for the data is illustrated through a flow chart in the supplementary material ( Supplementary Figure 1 ) and the key variables are self-reported citrus intake and urinary proline betaine. Briefly, dietary data was collected, over four consecutive days, using a four day semi-weighed food diary. Mean daily citrus intake (average citrus intake based on the four days of recording) was computed for the total citrus food group. The biomarker proline betaine has been previously presented a good biomarker of citrus intake with correlations of 0.9 with actual citrus intake. Furthermore, this has been demonstrated in different study settings by multiple research teams (9) (10) (11) (12) . Our previous work indicated that urinary proline betaine levels accurately estimated total citrus intake in a free living population group (7) .
The calibration equations method relies on a central assumption, that both self-reported and biomarker-derived estimates of intake of study participant i are linearly related to the so-called "true" intake X i , with the relations being perturbated by Gaussian errors. However, as true intakes are unknown, directly estimating such relationships is not possible. The calibration method overcomes this issue by deriving a conditional prediction of X i , X i , given the biomarker-derived estimates of intake M i (13) . Such conditional predictions are derived from the calibrated intakes W i , i.e. the self-reported intakes adjusted for measurement error:
The data analyzed herein refer to a study conducted on N = 1500 subjects, indexed by i = 1, … , N and collectively denoted A N , where food consumption data was recorded using 4 day semi weighed food diaries. Mean daily citrus intake W i (g/day) was computed for each subject. Also, biomarker-derived estimates of citrus intake M i were computed for a subsample of A N , here denoted A n , with n = 565. Self-reported data and biomarker estimated intake data for these n subjects were used to develop calibration equations. The estimated calibration equations were then employed to correct self-reported mean daily citrus intake W i for the remaining (N − n) = n * = 935 subjects, collectively denoted A n * .
The supplementary material provides a more detailed description of the calibration method.
Common problems that may be encountered with food intake data include zero inflation (14) , due the presence of non-consumers, and non-Gaussianity of the errors ϵ i . Potentially, such issues could result in poor correction of measurement error. In the literature, possible non-Gaussianity of the errors has been addressed using different transformations of the biomarker-derived estimates of intake, M i , such as the log transformation (15) or Box-Cox transformations (16) . In previous work (16) , zero-inflated data have been commonly modeled with the assistance of covariates. However, when such subject-specific information is not available, such an approach cannot be pursued.
In the present work, transformations of the biomarker-derived intake data have been considered for the estimation of calibration equations, as well as original scale biomarkerderived estimates of intake, to address potential non-Gaussianity of subject-specific errors.
Additionally, to address the issue of zero-inflated data in the absence of covariates, zeroinflated models have been explored and compared with a standard linear regression model, to select the optimal model specification for the calibration equations. The average mean squared error (MSE) between biomarker-derived estimates of intake and calibrated meandaily self-reported intake has been used to compare different model specifications and different transformations of the biomarker-derived intake data. The supplement presents more detail on the different models explored and gives a thorough discussion of the results obtained.
Estimation of the required portion of biomarker data in large studies
Acquisition of biomarker derived estimates of intake for all subjects may not be feasible in large population studies, due to high costs and limited biological samples availability. In order to estimate the required quantity of biomarker data needed in large studies a simulation study has been conducted. A set of P = 100 datasets of N = 100,000 subjects was created.
For each dataset p (p = 1, … , P) biomarker-derived estimates of intake and self-reported intake data have been simulated, according to the results obtained from the analysis of meandaily citrus intake data. Specifically, true mean-daily citrus intake values (g/day) have been simulated from a Gaussian distribution, with mean and variance fixed as the empirical mean and variance of the calibrated mean-daily self-reported citrus intakes. Self-reported and biomarker-derived intakes (g/day) have been then constructed from the simulated true intakes, following a classical calibration equations framework (17) . To represent different situations that could be encountered with real data, simulated self-reported and biomarker intakes may either have moderate or high variability around the "true intake". Such variation is regulated by the parameters α W and α M for self-reported and biomarker-derived intakes respectively. Also, different strengths of the association between self-reported and true intakes have been accounted for, to represent different self-reported data qualities. This feature is regulated by the parameter β W ; further detail on parameters α W, α M and β W are given in the supplement. Biomarker derived intakes are assumed to have been measured only for n g of the N subjects, with n g = gN and g = (0.01, 0.02, … , 0.99,1). For each value of n g , simulated intakes were used to estimate calibration equations, with the corresponding parameters being estimated via cross-validation (100 repetitions, excluding 20% of the observations at each round). Standard deviations of the estimated parameters, sd(β 0 ) and sd(β 1 ), were computed and compared for different values of n g , i.e. for different sizes of the sub-sample of subjects for which biomarker data are available. A stabilization of the parameter estimates indicates that, after a given n g , further increasing the number of subjects for which biomarker-derived intakes are computed would not yield a substantial improvement in measurement error correction. More details regarding the construction of the simulation study are given in the supplement, while the results are presented in the next section.
RESULTS
Estimating citrus intake using calibration equations
Summary statistics for self-reported and biomarker-derived mean daily citrus intakes (g/day) are reported in Concordance between self-reported and biomarker-derived intakes was confirmed by the statistics summarizing the conditional distributions M A n | W A n =0 and W A n | M A n =0 in Table 1 . These distributions represent, respectively, biomarker-derived intake values corresponding to null self-reported intake values and vice-versa. Such measures of intake display good agreement, as both take low values when the other is null.
Summaries of the predicted intakes obtained using different model specifications and biomarker transformations are compared in Table 2 . Models using a log-transform of the biomarker-derived estimates of intake in the estimation of the calibration equations, or of a Box-Cox transformation with small λ parameter, result in high-variability in the calibrated intakes. Indeed, regardless of the functional specification of the calibration equations, in these cases the standard deviation of the calibrated intakes is always greater than 792, much larger than the standard deviations of the observed self-reported intakes (sd(W A n * ) = 107, see Table 1 ). Also, when using these biomarker transformations, poor agreement is found between the interquartile ranges of the observed selfreported intakes and the calibrated intakes. The calibrated intakes from the remaining model specifications and biomarker transformations range in similar intervals, closer to that of the self-reported mean daily citrus intakes. Among these, the calibrated intakes computed using a linear regression model for the calibration equations with original-scale biomarker-derived estimates of intake (M i ) are those whose mean is closer to the mean of W A n * . Indeed, a linear regression model was optimal, in terms of MSE, to estimate calibration equations of citrus intake parameter Box-Cox transformation of M i , coinciding with a mere translation of the data. 8 Given the selected optimal linear model, mean-daily calibrated citrus intakes were computed 9 using the estimated calibration equations: 10 ̂= 33.60 + 0.63 11 It is worth noting that the estimated intercept is close to the average biomarker-derived 12 intake for non-consumers (see 13 Table 1 ). Figure 1 offers a comparison between calibrated and self-reported mean-daily citrus 14 intakes for the n * subjects in the validation study. Overall, there is good agreement between 15 self-reported and calibrated mean-daily intakes, however, differences emerge at high intakes. 16 Self-reported non-consumers were assigned to a low baseline citrus consumption level, 17 corresponding to β 0 = 33.60.
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What portion of biomarker data is required in large population studies? 19 Sixteen distinct scenarios of simulated intake data were generated by considering different 20 combinations of variability of self-reported data and biomarker data around the true intake, 21 quantified through α W , α M = (0.5,2), and self-reported data quality levels, quantified 22 through β W = (0.1,0.5,0.8,1). Among these, the group of "best-case" scenarios corresponds 23 to those with a α W = α M = 0.5, as both biomarker-derived intakes and self-reported intakes 24 have very little variability around true intakes. at an association between food intake and biomarker levels. Within this context, the use of 55 urinary proline betaine to correct self-reported citrus intake is a clear example of the potential 56 of the field of food intake biomarkers. Furthermore, we developed a framework for assessing 57 the amount of biomarker data needed in a large population study to correct for measurement 58 error in food intake. Interestingly, in the present simulation study biomarker data was 59 necessary for around 20-30% of the population highlighting an important aspect in the 60 translation of this work into large epidemiological studies. 61 To date, calibration equations for correction of measurement error have focused on nutrients 62 and to the best of our knowledge there is no example in relation to specific food intake. As 63 dietary guidelines move towards food-based guidelines it is imperative that we also have 64 good assessment of food intake. Use of food intake biomarkers has gained increased traction 65 in recent years with the promise of improvement in dietary assessment. The current 66 development of calibration equations for citrus intake clearly paves the path forward in this 67 regard. The ability to correct for measurement error for food intake has the potential to 68 enhance our understating of the relation between food and disease. Previous literature 69 demonstrated that correction of measurement error in nutrient intake using biomarkers led 70 to the identification of relationships that were not observed without the calibration. Using biomarkers to correct for measurement error, energy intake was associated with increased 72 risk of breast cancer, all cancer and type 2 diabetes and protein intake was associated with 73 increased risk of type 2 diabetes (4, (18) (19) (20) . Building upon the present work, the next step will 74 be to examine relationships between calibrated food intake and certain health parameters. 75 An important aspect of our approach was the development of calibrated intake distributions 76 which incorporate the uncertainty inherent in statistical modelling of measurement error. 77 Such an approach results in calibrated intake distributions instead of single point-estimates. 78 For researchers the potential distribution of intake delivers valuable information considering 79 the uncertainty surrounding self-reported data. To aid the end user to implement the citrus 80 intake calibration equations herein we developed a freely available web application, "Bio- figure is based on the strong assumption of very good quality self-reported data; small 121 deviations from this assumption can induce even larger uncertainty in the estimates. 122 Although being potentially onerous to achieve, the more conservative recommendation of 123 25% of cohort biomarker data is able to provide stable estimates independently of the self-124 reported data quality. Also, the simulation study was developed to analyze calibration 125 equations estimates for food biomarkers and its results may not have direct applicability in 126 the context of nutrient biomarkers. 127 Lastly, mean squared error values from the simulation study demonstrated that the quality 128 of analyzed self-reported data is quite relevant, even with high quality biomarker data. 129 Indeed, mean squared error values associated with "low data quality" scenarios (β W = 0.1) 130 were always much larger than those related to "higher data quality" ones (β W = (0.5,0.8,1) ). 131 More importantly, mean squared error distributions in "low data quality" scenarios did not 132 vary particularly with different variability levels in biomarker data (α W = (0.5,2)). In 133 conclusion, the simulation study findings suggest that calibration equations may be stably 134 estimated even with a relatively small portion of biomarker data, but that the quality of 135 calibrated intake predictions is strongly dependent on that of self-reported intake data. Large 
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Summary statistics for the citrus mean daily intake data (g/day). Self-reported mean daily intakes are reported for the entire sample ( ), subjects for which no biomarker data is available ( * ) and subjects for which biomarker-derived estimates of intake are computed ( ). The fourth column reports summary statistics for the biomarker-derived estimates of intake ( ). Table 2 Summary statistics for calibrated intake values using different calibration equations specifications, corresponding to various biomarker-derived intake data ( ) transformations and functional specifications. The calibrated intakes are those computed for the group of * subjects for which only self-reported mean daily citrus intake data (g/day) were available. Average mean squared errors computed between calibrated intakes and biomarker-derived estimates of intakes ( ), for the subjects in the study and different specifications of the calibration equations. The average MSE values for different specification of the Box-Cox parameter have been omitted, being all greater than the one obtained with = 1. Figure 1 Self-reported mean daily citrus intakes (g/day) and calibrated mean daily citrus intakes (g/day). For the calibrated intakes, 95% confidence intervals are reported (light grey). Intakes are ordered from lowest to highest values.
Two-part model
Figure Legends
Figure 2
Standard deviations of the estimated slope coefficient 1 are reported, for different sample sizes and different values of the parameter. These simulated scenarios represent the "best possible" ones in terms of data quality, as both self-reported and biomarker-derived estimates of intakes have low variability around the true intake values. Notice that the standard deviations tend to stabilize quickly, even in the "worst-case" scenario, that is when = 0.1.
Figure 3
Standard deviations of the estimated slope coefficient 1 are reported, for different sample sizes and different values of the parameter. These simulated scenarios represent the "worst possible" outcomes in terms of data quality, as both selfreported and biomarker-derived estimates of intakes have high variability around the true intake values. Notice that the standard deviations tend to stabilize quickly, even in the "worst-case" scenario, that is when = 0.1.
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THE CALIBRATION METHOD
The selection process for the data used to develop calibration equations is illustrated by Supplementary Figure 4 .
How it works
The calibration method is a measurement error correction technique widely used in nutrition literature (1) (2) (3) . The main assumption behind it states that self-reported intake data W i are linearly related to true intakes X i :
for subjects i = 1, … , N. The relation between the observed data W i and the latent quantity of interest X i is mainly influenced by two factors: the slope coefficient β W and the subjectspecific errors ϵ w,i . The β W parameter may be seen as a measure of the "quality" or the intensity of the relationship between self-reported and true intake data. Also, it expresses the direction of the relation between the two variables, with negative values of β W indicating disagreement. Subject-specific errors ϵ w,i represent individual variability in self-reported intakes. Such errors are assumed to be normally distributed with zero mean and homoscedastic, i.e. with equal variances σ w 2 . Thus, the calibration method assumes there is no interaction between the subjects when reporting the intakes, a reasonable assumption in many nutrition studies, as reports are collected separately. Also, by assuming equal error variances σ w 2 , the calibration method implies that subjects are equally likely to misreport their consumption, hence all subjects are equally reliable. The linear relation between self-reported and true intake data cannot be estimated, as the latter is not observed. To overcome such issue, the calibration method relies on a second assumption: another linear relation exists between biomarker-derived (M i ) and true intake data:
Further, it is assumed that biomarker-derived estimates of intake provide a more reliable representation of true intakes, setting β M = 1 and μ M = 0, thus following the classical measurement error model REF here Carroll book 2006. Subject-specific errors ϵ M,i are assumed to be independently distributed, according to a Gaussian distribution with zero mean and equal variance σ M 2 . As the true intakes X i cannot be observed, the calibration method combines equations (1) and (2) to derive estimates of such quantities. Specifically, given the assumptions outlined hold, X i may be conditionally predicted given biomarker-derived estimates of intakes and selfreported intakes in two steps:
M i = β 0 + β 1 W i + ϵ i , i = 1, … , n X i = β 0 + β 1 W i , i = 1, … , n
The errors ϵ i are within-subject random effects, distributed independently according to a standard Gaussian distribution. The above equations are the so-called "calibration equations" and the predicted true intakes X i are the calibrated self-reported intakes. Indeed, the estimates of the fixed effect population level parameters β 0 and β 1 may be used to correct self-reported data and get more reliable estimates of true intake; note that such correction incorporates the information coming from biomarker-derived data, but it does not directly depend on it. (4) provides detail on the construction, implementation and theoretical justification of the calibration method.
Alternative model formulations
Intake data is often characterized by a large presence of zero values. Depending on whether the measure of intake is self-reported or biomarker-derived, zero values either indicate nonconsumers (subjects that reported null consumption of a given food) or null biomarkerderived estimates. There may be a partial mismatch between subjects self-reporting zero intake values and those having zero biomarker-derived estimates of intake values. When subject-specific covariates have been collected, several approaches, eg. (5) , have been proposed to incorporate them in the modelling framework and to try modelling "true" and "false" (those misreporting) non-consumers. In the absence of covariate data such zero selfreported intakes are more challenging to address, but modelling frameworks designed for zero-inflated data can be exploited eg. (6) . In particular, the calibration equations may be redefined according to either a Tobit model (7) or a two-part model (8) ; such models are designed specifically for a regression framework where the response variable, M i , is semicontinuous. Then, the calibration equations may be rewritten as:
The function f l (⋅) is a link function, corresponding to the linear regression, the Tobit regression or the two-part regression, respectively for l = 1,2,3.
Biomarker transformation
The assumption of Gaussian errors ϵ i may not be completely satisfied in empirical studies, and some skewness may be found in observed intake data. As can be seen from the summary statistics provided in the paper, this is the case for the observed mean daily self-reported intakes and biomarker-derived estimates of citrus intake. In particular, when deriving calibration equations for citrus intake, the skewness in the distribution of biomarker-derived estimates of intake may imply non-Normality of the errors ϵ i . To try overcome this potential issue, in the context of episodically consumed foods (5) propose to transform the response variable using the Box-Cox family of transformations (9) ,
so that the distribution of the transformed marker data M i * would more closely resemble that of a Gaussian. Using a Box-Cox transformation of biomarker-derived intakes, the calibration equations may be defined as:
M i * = f l (W i ) + ϵ i , i = 1, … , n X i * = f l (W i ) where X i * is the transformed predicted true intake and f l (⋅) is any given model specification for the calibration equations. Predicted intakes on the original scale may be found by computing the inverse of the Box-Cox transformation, X î = BC −1 (X i * , λ), using the Delta method (10):
Note that when biomarker-derived intake data are transformed using a Box-Cox transformation, the two-part and Tobit model can no longer be estimated, as structural zeros "disappear" in the transformed variable. A different transformation that attempts to normalize the data while leaving the structural zeros unchanged is the log-transformation M i * = log(M i + 1). This type of log-transformation is widely used in dose-response study data, where there is often the need to rescale the data without losing information on the structural zero values. Indeed, for M i = 0, M i * = log(1) = 0. As for Box-Cox transformed intake data, when using log-transformed biomarker-derived estimates of intake to estimate calibration equations, the computed calibrated intakes are defined on a new, transformed, scale. Calibrated intake on the original scale may be obtained using the back transformation X i = 3 2 exp(X i * ) − 1.
Estimating calibration equations: cross validation and mean squared error
In order to select the optimal model specification, 
̂, , =̂( , , )
When using transformed biomarker-derived estimates of intake, in equations (3) and (4), M i,k,t train may be substituted with the transformed-intake M i,k,t train, * , and X i,k,t test would then be the transformed-calibrated intake X i,k,t test, * .
To compare calibrated intakes obtained with different calibration equations models ℳ k , k = 1, … , K, mean squared errors are computed, between the known biomarker-derived intake values M i,k,t test and the calibrated intake values X i,k,t test :
Different models may then be compared using average mean square errors MSE ̅̅̅̅̅̅ k = ∑ MSE k,t / T t=1 T, with lower values corresponding to better models. Thus, the optimal model ℳ k * may be found as k * = arg min k MSE k ̅̅̅̅̅̅̅ .
SIMULATION STUDY
The calibration equations framework is built upon the assumption that both self-reported intakes and biomarker-derived estimates of intake are linearly related to the unknown true intakes. Normally, biomarker-derived intakes are collected only for a sub-sample of the population of interest, due to elevated extraction costs. Indeed, in the mean daily citrus intake data the population of interest counted N = 1500 subjects, but biomarker-derived intakes had been collected only for n = 565 of them, approximately one third of the total. With large population studies, it may be infeasible to collect biomarker-derived intakes for a large subset of the subjects. Biomarker-derived data would be then collected only for a small number of n subjects, n ≪ N. However, deriving calibration equations using n ≪ N observations may result in unstable and potentially unreliable intake predictions. Hence, how large, or small, n is required to be in order to obtain stable predictions is of key interest. To investigate this issue, a simulation study has been constructed. Assuming the population of interest has N = 100,000 subjects, P = 100 different sets of true, self-reported and biomarker-derived mean daily citrus intakes have been simulated according to the calibration equations framework: W i,p = μ W + β W X i,p + ϵ i,p,W M i,p = X i,p + ϵ i,p,M True intakes X i,p have been simulated from a Gaussian distribution X i,p~( μ X , σ X 2 ), where μ X = 81 and σ X 2 = (66) 2 have been fixed to reflect the estimated mean and variance of the calibrated mean daily citrus intakes. The random errors, ϵ i,p,W and ϵ i,p,M are assumed to be normally distributed with zero mean and variances σ W 2 = α W σ X 2 and σ M 2 = α M σ X 2 . The α W and α M scale parameters regulate the variation of the self-reported and biomarker-derived intake data around the true intake. These scale parameters have been set to α W , α M = (0.5,2), to represent both clean (α W , α M = 0.5) and noisy (α W , α M = 2) intake data. The β W parameter measures the strength of the relation between self-reported and true intake data. To represent different levels of quality for self-reported data, this parameter has been set to β W = (0.1,0.5,0.8,1), with β W = 0.1 and β W = 1 denoting poor and good data quality, respectively. Finally, the offset parameter μ W measures the average difference between selfreported and true intake data. Here this parameter has been set to μ W = 0, as similar values were observed for the average self-reported and calibrated mean-daily intakes. Different combinations of β W , α W and α M parameter values give rise to sixteen different simulation scenarios. For each scenario, it has been further assumed that biomarker-derived estimates of intake have been collected for a subsample of n g subjects, with n g = gN and g = (0.01, 0.02, … , 0.99,1). For each simulation scenario and for each value of n g the calibration equations are estimated, using the optimal model from the citrus intake data analysis i.e. the linear model with the original-scale biomarker-derived intakes. As in the citrus intake analysis, calibration equations have been estimated using the "leave-p-out cross-validation" method. The standard deviations of the cross-validation estimates of the calibration equation parameters, sd(β 0 ) α W ,α M ,β W ,n g ,p and sd(β 1 ) α W ,α M ,β W ,n g ,p are then computed. Finally, these standard deviations are averaged across the P different simulated datasets giving sd(β 0 ) α W ,α M ,β W ,n g and sd(β 1 ) α W ,α M ,β W ,n g . For each scenario, these averaged standard deviations are explored for increasing number of biomarker-derived intake estimates n g . Small decrements of the standard deviations with increasing n g would indicate no improvement in parameter estimate stability as a result of, expensively, collecting greater portions of biomarker data.
Simulation study results
Supplementary Figure 5 Simulations. This figure presents the distributions of the MSE computed in the different simulation scenarios, between simulated and calibrated mean daily intakes. As expected, the error is lower when both self-reported and biomarker-derived intakes have little variability around true intakes, and it decreases with increasing values of . However, when self-reported intake data is of "poor" quality ( = 0.1), the MSE is not much affected by the noise level ( , ).
Supplementary Figure 6 Standard deviations of the estimated intercept 0 in the different scenarios, for different sample sizes and different values of the parameter. As for the estimated slope coefficient 1 , standard deviations tend to stabilize quickly, independently of the scenario considered. Supplementary Figure 7 Standard deviations of the estimated slope coefficient 1 in the two intermediate scenarios, for different sample sizes and different values of the parameter. As for the other scenarios, standard deviations tend to stabilize quickly, even with "poor" self-reported data quality, that is for = 0.1.
